Med Journal Rule Harms Patient Privacy, Pharma Group Says
A U.S. pharmaceutical industry group on Monday criticized the British Medical Journal's decision to publish only studies for which patient-level clinical trial data is made public, arguing it threatens patients' privacy...To view the full article, register now.
Already a subscriber? Click here to view full article